A pharmacy in the city
of Hamilton, Ontario has
denied allegations of diluting
chemotherapy drugs, after an
investigation found that more than
1000 cancer patients across the
region received doses about 20%
lower than prescribed.
Marchese Health Care, which
supplied the chemotherapy drugs
to several hospitals in the region,
instead blamed the “manner
of administration used in some
hospitals that was not aligned with
how the standardised preparation
had been contractually specified”.
Cancer Care Ontario is probing
the matter in which 1076
patients received lower doses of
gemcitabine and cyclophosphamide
over the last 12 months.
A law firm has already been
retained in connection with a class
action lawsuit over the controversy.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Apr 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Apr 13
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.